These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15010501)

  • 1. The nitric oxide donor, O2-vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (V-PYRRO/NO), protects against cadmium-induced hepatotoxicity in mice.
    Liu J; Qu W; Saavedra JE; Waalkes MP
    J Pharmacol Exp Ther; 2004 Jul; 310(1):18-24. PubMed ID: 15010501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced hepatotoxicity in mice.
    Liu J; Li C; Waalkes MP; Clark J; Myers P; Saavedra JE; Keefer LK
    Hepatology; 2003 Feb; 37(2):324-33. PubMed ID: 12540782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O(2)-Vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate protection against D-galactosamine/endotoxin-induced hepatotoxicity in mice: genomic analysis using microarrays.
    Liu J; Saavedra JE; Lu T; Song JG; Clark J; Waalkes MP; Keefer LK
    J Pharmacol Exp Ther; 2002 Jan; 300(1):18-25. PubMed ID: 11752092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited protective role of V-PYRRO/NO against cholestasis produced by alpha-naphthylisothiocyanate in mice.
    Liu J; He YY; Chignell CF; Clark J; Myers P; Saavedra JE; Waalkes MP
    Biochem Pharmacol; 2005 Jul; 70(1):144-51. PubMed ID: 15913567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nitric oxide prodrug, V-PYRRO/NO, protects against cadmium toxicity and apoptosis at the cellular level.
    Qu W; Liu J; Fuquay R; Shimoda R; Sakurai T; Saavedra JE; Keefer LK; Waalkes MP
    Nitric Oxide; 2005 Mar; 12(2):114-20. PubMed ID: 15740985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The liver-selective nitric oxide donor O2-vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (V-PYRRO/NO) protects HepG2 cells against cytochrome P450 2E1-dependent toxicity.
    Gong P; Cederbaum AI; Nieto N
    Mol Pharmacol; 2004 Jan; 65(1):130-8. PubMed ID: 14722244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics.
    Kus K; Walczak M; Maslak E; Zakrzewska A; Gonciarz-Dytman A; Zabielski P; Sitek B; Wandzel K; Kij A; Chabowski A; Holland RJ; Saavedra JE; Keefer LK; Chlopicki S
    Drug Metab Dispos; 2015 Jul; 43(7):1028-36. PubMed ID: 25870102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced nephrotoxicity in mice.
    Li C; Liu J; Saavedra JE; Keefer LK; Waalkes MP
    Toxicology; 2003 Aug; 189(3):173-80. PubMed ID: 12832150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nitric oxide prodrug, V-PYRRO/NO, mitigates arsenic-induced liver cell toxicity and apoptosis.
    Qu W; Liu J; Fuquay R; Saavedra JE; Keefer LK; Waalkes MP
    Cancer Lett; 2007 Oct; 256(2):238-45. PubMed ID: 17658681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V-PYRRO/NO downregulates mRNA expression levels of leukotriene C4 synthase during hepatic ischemia reperfusion injury in rats via inhibition of the nuclear factor-κB activation pathway.
    Hong FF; Wang YF; Liu H; Yang MW; Yang SL
    Biomed Rep; 2016 Jan; 4(1):112-116. PubMed ID: 26870346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V-PYRRO/NO: an hepato-selective nitric oxide donor improves porcine liver hemodynamics and function after ischemia reperfusion.
    Ricciardi R; Foley DP; Quarfordt SH; Saavedra JE; Keefer LK; Wheeler SM; Donohue SE; Callery MP; Meyers WC
    Transplantation; 2001 Jan; 71(2):193-8. PubMed ID: 11213058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of a liver-selective nitric oxide-releasing agent, V-PYRRO/NO, by human microsomal cytochromes P450.
    Inami K; Nims RW; Srinivasan A; Citro ML; Saavedra JE; Cederbaum AI; Keefer LK
    Nitric Oxide; 2006 Jun; 14(4):309-15. PubMed ID: 16545970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The liver-selective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet.
    Maslak E; Zabielski P; Kochan K; Kus K; Jasztal A; Sitek B; Proniewski B; Wojcik T; Gula K; Kij A; Walczak M; Baranska M; Chabowski A; Holland RJ; Saavedra JE; Keefer LK; Chlopicki S
    Biochem Pharmacol; 2015 Feb; 93(3):389-400. PubMed ID: 25534988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver.
    Saavedra JE; Billiar TR; Williams DL; Kim YM; Watkins SC; Keefer LK
    J Med Chem; 1997 Jun; 40(13):1947-54. PubMed ID: 9207935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. V-PROLI/NO, a nitric oxide donor prodrug, protects liver cells from arsenic-induced toxicity.
    Qu W; Liu J; Dill AL; Saavedra JE; Keefer LK; Waalkes MP
    Cancer Sci; 2009 Mar; 100(3):382-8. PubMed ID: 19154403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein.
    Liu Y; Kreppel H; Liu J; Choudhuri S; Klaassen CD
    J Pharmacol Exp Ther; 1993 Jul; 266(1):400-6. PubMed ID: 8331568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity.
    Liu J; Liu Y; Michalska AE; Choo KH; Klaassen CD
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1216-23. PubMed ID: 8786554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide and chemically induced hepatotoxicity: beneficial effects of the liver-selective nitric oxide donor, V-PYRRO/NO.
    Liu J; Waalkes MP
    Toxicology; 2005 Mar; 208(2):289-97. PubMed ID: 15691592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of fulvotomentosides on cadmium-induced hepatotoxicity.
    Liu YP; Liu J; Jia XS; Mao Q; Klaassen CD
    Zhongguo Yao Li Xue Bao; 1992 May; 13(3):213-7. PubMed ID: 1442101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the nitric oxide donor V-PYRRO/NO on portal pressure and sinusoidal dynamics in normal and cirrhotic mice.
    Edwards C; Feng HQ; Reynolds C; Mao L; Rockey DC
    Am J Physiol Gastrointest Liver Physiol; 2008 Jun; 294(6):G1311-7. PubMed ID: 18356534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.